Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

August 1, 2019

Conditions
EpilepsyNocturnal Enuresis
Interventions
OTHER

Clinical, EEG and laboratory assessment at presentation

"* The patients' history, clinical, demographic, and laboratory data were acquired.~* The following tests and imaging studies are routinely done for epilepsy patients receiving valproate treatment and developed nocturnal enuresis, blood urea nitrogen (BUN), serum creatinine (Cr), urinary pH (before and after valproate therapy beginning and at enuresis onset), serum levels and therapeutic doses of valproate.~* Urinary tract ultrasonography (with full and void bladder).~* CT brain and EEG."

DRUG

Valproate

valproate monotherapy

Trial Locations (1)

Unknown

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER

NCT04191863 - Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children. | Biotech Hunter | Biotech Hunter